|
Open Access -Title
|
Ultrasound detection of mammary duct dilatation after breastfeeding cessation |
|
|
Συγγραφέας – Author
|
G. Dorovinis, S. Zervoudis, G. Iatrakis, A. Bothou, S. Kalantaridou Rea hospital, Athens, Greece |
|
|
Citation
|
G. Dorovinis, S. Zervoudis, G. Iatrakis, A. Bothou, S. Kalantaridou.Ultrasound detection of mammary duct dilatation after breastfeeding cessation. Review Clin. Pharmacol. Pharmacokinet. 2023, 37, 1, 5-9. DOI:10.5281/zenodo.10051846 |
|
|
Publication Date
Republication Date
|
05-01-2023
27-10-2023
|
|
|
Full Text Language
|
English |
|
|
Keywords
|
cabergoline, ductal dilatation, weaning, lactation, breastfeeding, lactation inhibition
|
|
|
Other Terms
|
Clinical Study |
|
|
Summary
|
Mammary duct ectasia was assessed after breast feeding in two groups of patients; without any medication and with cabergoline. The group treated with this medicine presented a reduction of the duct dilatation. | |
| References | 1. Hamwi MW, Winters R. Mammary Duct Ectasia. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing 2022, PMID: 32491597, Bookshelf ID: NBK557665. 2. Iatrakis G. Breast Imaging. In: Gynecologic Oncology. Athens, Greece, Zevelekakis ed. 2020 3. Wood JR. Mammary Duct Ectasia: Symptomatology, Diagnosis, and Treatment. Radiol Technol 2021, 92:383M-98M 4. Cabergoline: Drug information. UpToDate 2022. 5. Mohammed AA. Mammary duct ectasia in adult females; risk factors for the disease, a case control study. Ann Med Surg (Lond) 2021, 62:140-44. 6. Rahal RM, de Freitas-Júnior R, Paulinelli RR. Risk factors for duct ectasia. Breast J 2005, 11:262-5. 7. Eglash A. Treatment of maternal hypergalactia. Breastfeed Med 2014, 9:423-5. 8. Zervoudis S,Iatrakis G,Galazios G,Liberis V,Tsikouras P,Koutlaki N, Mastorakos G,Badiu C.Quinagolide effects in normoprolactinemic galactorrhea. Breast J.2014 Mar-Apr;20(2):221-3. |
|
|
Relative Papers
|